Skip to content
★ Sign in to follow
JM

Jeffrey M. Dayno

Directeur Médical
Insider activity · 24 months0 buys3 salesCumulative net flow
Total declarations
41
Companies
2
▲ Purchases (0 ops.)
—
▼ Sales (22 ops.)
€5.0M

Latest filing published 26 Jan 2026 for Harmony Biosciences Holdings, Inc..

Filing timeline

BuySale
Jeffrey M. Dayno

Insider track record

Disclosed buys
0
Disclosed sells
22
Signal history

Jeffrey M. Dayno: trading record in brief

This profile gathers the share dealings of Jeffrey M. Dayno across 2 companies, led by Harmony Biosciences Holdings, Inc. and Egalet Corp. In total, 41 filings cover trades dated from 6 August 2014 to 25 January 2026.

Every open-market trade on record is a sale: 22 sales worth €5.0M. Outside the open market, there are 4 share grants and 15 option exercises.

The latest filing, published on 26 January 2026, reports an option exercise in Harmony Biosciences Holdings, Inc. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.

Companies and markets linked to Jeffrey M. Dayno

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations41 total

25 of 41 declarations